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compared with RAW-chimera.
Introduction 50
Numerous microbes are covered with the polysaccharides. Recognition of the 51 polysaccharides by pattern recognition receptors (PRRs), including lectins, is vital in order to 52 recognize pathogens, since recognition of the outermost components is the first interactive step 53 with immune cells during infection to evoke innate and adaptive immune responses. 54
Candida albicans is an opportunistic agent of infection in immune compromised 55 patients. In the host innate immune system, several types of receptors for sensing ligands on the 56 microbe have been defined, e.g., C-type lectins and toll-like receptors (TLRs) (18). Ligands for 57 these receptors are present in the outer structure of microbes. However, some ligands are 58 sequestered by the outermost polysaccharides, which consist of mannoproteins, as reported in the 59 case of β-glucan, a ligand for Dectin-1 (6). Mannoproteins are rich in polysaccharides composed 60 of mostly α-and β-mannose and recognized by mannose/mannan type lectins. 61 C-type lectin human (h)DC-SIGN (CD209) has been shown to interact with a wide 62 range of pathogens, including microbes, viruses and protozoa (11) via mannose and fucose 63 moieties on the surface of the pathogens. Microbes such as Mycobacterium tuberculosis and C. 64 albicans are endocytosed and processed for antigen presentation to induce the subsequent T 65 cell-mediated immune responses. However, the recognition also induces immunosuppressive 66 responses in cooperation with TLRs (8). 67
Mice have eight hDC-SIGN homologues (19, 20) . One of these homologues, SIGNR1, 68
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is structurally related to hDC-SIGN based on its long neck domain. SIGNR1 is expressed on 69 particular subsets of macrophages (Mφ)/dendritic cells (DC) in the marginal zones of the spleen, 70 resident peritoneal cavity, medulla of lymph nodes, skin and lamina propria (4, 10, 17, 30). 71 SIGNR1 on these cells plays a role as a sentinel in the recognition of pathogens through capsular 72 polysaccharides. In fact, SIGNR1 on marginal zone Mφ recognizes Streptococcus pneumoniae 73 (10), leading to efficient activation of the complement system in situ (9) . 74
Previously, we reported that SIGNR1 recognizes Gram-negative bacteria (Salmonella 75 typhimurium and Escherichia coli) and C. albicans (27) . The former are recognized through their 76 non-reductive end of the lipopolysaccharide core sequence by SIGNR1 (17) . This is also the case 77 of hDC-SIGN in recognition of E. coli (13) . Recently, hDC-SIGN has been reported to strongly 78 recognize the α-mannose structure of N-glycan side chains of C. albicans, but weakly that of S. 79 cerevisiae (2). However, the recognition motif on C. albicans by SIGNR1 is not clear at present. 80 Therefore, we aimed to elucidate the properties of SIGNR1 in the recognition of 81 polysaccharide on C. albicans. To this end, we prepared soluble forms of SIGNR1 (sSIGNR1) 82 and hDC-SIGN (shDC-SIGN) and used structurally distinguished glycans purified from various 83 types of C. albicans and S. cerevisiae as well as respective microbes. The results indicate that 84 sSIGNR1 binds equally well to glycans from S. cerevisiae as to C. albicans. Furthermore, 85 sSIGNR1, but not shDC-SIGN, was shown to readily recognize C. albicans glycan treated with 86 α-mannosidase. In addition, a glyco-microarray based on an evanescent-field fluorescence 87
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detection method clearly revealed that sSIGNR1 binds α-mannose monosaccharide and mannans 88 from C. albicans and S. cerevisiae, but dose not recognize Lewis a/b/x/y antigen polysaccharides as 89 in shDC-SIGN. Different properties in recognition of yeast glycans between SIGNR1 and 90 hDC-SIGN CRD were also observed in induction of IL-10 from RAW264.7 cells. 91 (sLectin) tetramers, such as sSIGNR1 and shDC-SIGN, were prepared as described (26). Briefly, 130 cDNA fragments encoding their extracellular domains were cloned into pEXPR-IBA44 (IBA, 131
Göttingen, Germany) to add N-terminal BM40 secretion signal and Strep-Tag II sequences, 132 followed by the transfer into pEF6/V5-His (Invitrogen). HEK293T cells were then transfected 133 with each plasmid using the calcium phosphate method (3) and cultured in serum-free medium 134 293 SFM II (Invitrogen) for the last 48 hr. sSIGNR1 and shDC-SIGN in the supernatant were 135 purified using Strep-Tactin Sepharose (IBA) in accordance with the manufacturer's protocol (> 136
95% of purity by SDS-PAGE). 137
Purified sLectins (2.5 µg/ml) were incubated with PE-labeled Strep-Tactin (7.5 µg/ml) 138 in 18 µl of Hanks' balanced salt solution (pH 8.3) (binding buffer) for 2 h at 4°C and for a further 139 10 min at 37°C. The tetramers thus formed were incubated with 5 x 10 6 live microbes for 4 h at 140 4°C in the presence of 1% BSA (total volume 25 µl). After washing with the binding buffer, the 141 amount of bound PE-Strep-Tactin was measured by Gemini EM (Molecular Devices, Sunnyvale, 142 CA). The direct binding of sSIGNR1 is shown as an arbitrary unit of fluorescence intensity. 143
The % inhibition was calculated using the following formula: [1 -(fluorescence intensity of C. 144 albicans by the staining with sLectin plus inhibitor -that without sLectin) / (that with sLectin 145 without inhibitor -that without sLectin)] x 100. 146 147 Lectin ELISA. sSIGNR1 and shDC-SIGN were formed by incubating sLectins (62.5 ng) with 148 HRP-Strep-Tactin (12.5 ng) in 20 µl of the solution as above. Microtiter plates were coated with 149 50 µl of mannan/glycan (5 mg/ml) in 50 mM sodium bicarbonate buffer (pH 9.6) for 12 h at 4°C, 150 followed by the incubation with 2.5% BSA at room temperature for 2 h after washing with 25 151 mM Tris-HCl pH8.3 + 150 mM NaCl. The plates were then incubated with sSIGNR1 or 152 shDC-SIGN in the presence of 1% BSA for 2 h at 4°C. For inhibition experiments, sLectin 153 tetramer was pre-incubated with inhibitors for 1 h at 4°C before adding to plates. After washing, 154 binding of sLectin tetramer was measured as the absorbance of TMB (eBioscience) at 450 nm by 155
VERSAmax (Molecular Devices). The % inhibition was calculated as above. 156 157 Inhibition of FITC-dextran binding to RAW-SIGNR1 with glycans. RAW-SIGNR1 cells (2 158
x 10 5 cells) were pre-incubated with various types of glycan and EDTA (25 mM) for 30 min at 159 4ºC and then mixed with 80 µg/ml of FITC-dextran (2,000 kDa; Sigma-Aldrich) for 4 h at 4ºC. 160
Binding of FITC-dextran was analyzed by a flow cytometer. The % inhibition was calculated 161 using the following formula: [1 -(mean fluorescence intensity (MFI) of RWA-SIGNR1 cells 162 with FITC-dextran plus inhibitor-that without FITC-dextran) / (that with FITC-dextran without 163 inhibitor -that without FITC-dextran)] x 100. 164 165
Glyco-microarray analyses of sLectins by evanescent-field fluorescence detection. The 166
glyco-microarray analysis was performed as described (28). To form immune complex, sSIGNR1 and shDC-SIGN (10 µg/ml) were pre-incubated with Alexa647-anti-SIGNR1 (22D1) 168
and Alexa555-anti-hDC-SIGN (DCS-8C1; 1 µg/ml) for 15 min at room temperature in 25 mM 169
Tris-HCl buffer (pH 7.4) containing 0.8% NaCl, 1% (v/v) Triton-X100, and 2 mM CaCl 2 with or 170 without 10 mM EDTA. This complex was directly added to the array immobilized with 171 multivalent glycan ligands ( Supplementary Fig. S1 ), followed by incubation overnight at 20°C. 172
Binding was then detected using an evanescent-field fluorescence-assisted scanner. Data were 173 analyzed with the Array Pro analyzer ver. 4.5 (Media Cybernetics, Bethesda, MD). 174 175 IL-10 production of RAW264.7 transfectants by stimulation in microplates coated with 176 glycan. Non-treated plates were pre-coated with 600 µg/ml glycan in PBS for 12 h. After 177 blocking with RPMI1640 containing 10% FCS for 30 min, RAW264.7 transfectants (5 x 10 4 178 cells) were cultured in the presence of 100 ng/ml ultra pure LPS (Invitrogen) for 24 h. IL-10 in 179 the supernatants was analyzed using the Cytometric Bead Array (CBA) for mouse inflammation 180 kit (BD Biosciences, Franklin Lakes, NJ). Therefore, we first examined the direct binding of sSIGNR1 to several Candida strains 192 ( Fig. 1B ). We used sSIGNR1 tetramerized with Strep-Tactin, because the affinity of sSIGNR1 193 monomer is weak (20). This method not only helps to increase the affinity of sSIGNR1 but also 194 helps to avoid the formation of large complexes using Fc-fusion lectins polymerized with anti-Fc 195 polyclonal Ab. Before using this sSIGNR1-tetramer for experiments, we confirmed that 196 sSIGNR1-tetramer bound to mannan-agarose was eluted with EDTA (data not shown), although 197 the yield was less than half the amounts applied. sSIGNR1 bound clinical isolate live C. albicans 198 JCM1542 (serotype A) in an EDTA-sensitive manner, indicating that sSIGNR1 binding occurs 199 via the carbohydrate recognition domain (CRD). The other clinical isolate strains, C. albicans 200 J-1012 (serotype A) and NIH B-792 (serotype B), were also recognized by sSIGNR1, although 201 sSIGNR1 binding was much less to nosocomial strain C. lusitaniae. 202
It is of note that sSIGNR1 binds to S. cerevisiae comparably to clinical isolate C. were conducted using N-glycans from the various yeast strains listed ( Fig. 1A and Table I) . 210
The direct binding of sSIGNR1 to C. albicans J-1012 N-glycan, which is composed of 211 complexed side chains, was inhibited by glycans from several types of microbes: C. albicans 212 NIH B-792 and C. stellatoidea glycans lacking β1,2-mannose, C. parapsilosis glycan 213 lacking β1,2-mannose and α1,6-branched mannose, and S. cerevisiae WT glycan composed of 214 short side chains lacking β1,2-mannose and α1,6-branched mannose ( Fig. 2A ). These glycans 215 share the α1,2-mannose side chain structure, suggesting that SIGNR1 recognizes similar moiety 216 in N-glycan as hDC-SIGN (2). Moreover, S. cerevisiae 4484-24D-1 (mnn1/mnn4) glycan, which 217 lacks phosphorylated mannose (PM), β1,2-mannose, α1,3-mannose, and α1,6-branched mannose 218 but possesses the short (mono-or di-) mannose side chain structure, appeared to be recognized 219 by SIGNR1. However, S. cerevisiae X2180-1A-5 (mnn2) glycan, which lacks all side chains, 220 wasn't effective ( Figs. 2A and B ), suggesting the crucial involvement of the side chain structure. 221
In addition, C. lusitaniae glycan, the side chain of which is composed of more than 75% of 222 β1,2-mannose (mono-~ tri-β-mannose)-capped side chain (23), was also ineffective in inhibiting 223 the sSIGNR1 binding ( Figs. 2A and B ), implying that these β1,2-mannoses disturb the access of 224 SIGNR1 to the α-di-mannose to some extent. Glycogen itself had no effect. As in the case of 225 sSIGNR1 binding to microbes, that to C. albicans J-1012-derived N-glycan was EDTA-sensitive 226 ( Fig. 2A) . 227
Interestingly, treatment of C. albicans J-1012 mannan with α-mannosidase, which 228 removed the α-mannose side chains other than the β1,2-mannose-capped side chains (see Fig.  229 1B) (14), did not affect the inhibitory activity ( Fig. 2A ). This result also indicates that 230 β1,2-mannose capped α-mannose side chains in the N-glycan are sufficient to be recognized by 231 SIGNR1. We also obtained similar results when mannan from S. cerevisiae (M7504; 232
Sigma-Aldrich) was employed to coat plastic plates in lectin ELISA (data not shown). Therefore, 233 it is feasible that SIGNR1 recognizes long internal α-mannose (tri-or more-mannose) capped 234 with β1,2-mannose in addition to α-mannose side chains. 235
Since RAW-SIGNR1 cells effectively bind and endocytose high molecular weight 236 FITC-dextran in an EDTA-sensitive manner (27), we carried out the inhibition analysis using 237 RAW-SIGNR1 cells to bind FITC-dextran instead of lectin ELISA (Fig. 2C ). The inhibition 238 activities of glycans from C. albicans J-1012 and NIH B-792, and S. cerevisiae and its mutant 239 (mnn1/mnn4) were again comparably effective. The treatment of C. albicans J-1012 glycan with 240 α-mannosidase was also ineffective in reducing the inhibitory activity. In addition, low 241 efficiencies of glycans from S. cerevisiae (mnn2) and C. lusitaniae were also confirmed in this 242 experimental system. When resident peritoneal Mφ that express SIGNR1 (27) were used, similar results were obtained (data not shown). Together with the results using N-glycan only consisting 244 of α-mannose in side chain, these results strengthen the possibility that SIGNR1 recognizes both 245 α-mannose side chain and β1,2-mannose capped α-mannose side chains composed of more than 246 tri-mannoses in N-glycan. hDC-SIGN recognizes glycans of S. cerevisiae strains less efficiently than those of Candida 250 strains (2). In contrast, SIGNR1 equally recognized glycans from both wild type and mnn1/mnn4 251 mutant of S. cerevisiae as C. albicans, suggesting that the specificities of hDC-SIGN and 252 SIGNR1 are somehow different from each other. In order to examine this possibility, we 253 prepared shDC-SIGN and compared the sugar specificity with that of sSIGNR1. 254
In lectin ELISA, the binding of shDC-SIGN to C. albicans J-1012 glycan was more 255 sensitive to fucose than mannose, and less sensitive to glucose and GlcNAc (Fig. 3A) , as 256 reported (16). Results using this probe showed that shDC-SGIN bound comparably well to C. 257 albicans J-1012 and NIH B-792 ( Fig. 3B ). Unlike sSIGNR1, shDC-SIGN bound less to S. 258 cerevisiae microbes, as reported (2). 259
In addition, shDC-SIGN binding to C. albicans J-1012 glycan was not efficiently 260 blocked by glycans from S. cerevisiae and mnn1/mnn4 mutants ( Fig. 3C ), indicating different 261 specificity in N-glycan recognition between hDC-SIGN and SIGNR1. It is worth noting that 262 treating C. albicans J-1012 glycan with α-mannosidase dramatically reduced its inhibitory 263 activity ( Fig. 3C ). We further confirmed the abrogation of inhibitory activity of N-glycan from C. 264 albicans J-1012 by α-mannosidase treatment by titrating its dose (Fig. 3D) , showing that the 265 reduced activity is nearly comparable to that of S. cerevisiae. These results suggested that 266 hDC-SIGN only recognizes the α1,2-mannose at the non-reductive end of α-mannose side 267 chains, but not the internal α1,2-mannose capped with β1,2-mannose and short α-mannose 268 chains that are recognized by SIGNR1, of the N-glycan side chains in mannoprotein. 269
It has been reported that another SIGNR lectin, SIGNR3, also recognizes C. albicans 270
(27) and that its saccharide specificity resembles that of hDC-SIGN (20). Based on the inhibition 271 assay using lectin ELISA, SINGR3 was shown to bind a little more efficiently to wild type and 272 the mnn1/mnn4 mutant of S. cerevisiae than hDC-SIGN but less so than SIGNR1 273 ( Supplementary Fig. S2 ). Of note, SIGNR1 did not recognize fucose-containing moieties, such as Fucα2Gal and 287 Lewis a/b/x/y antigen. The binding of sSIGNR1 to heparin is likely to be false positive, because of 288 the insensitivity to EDTA. 289
We previously performed array analyses using shDC-SIGN-Fc fusion as a probe (28). 290
However, structural forms between SIGNR1 and shDC-SIGN-Fc were different and this made it 291 difficult to compare the precise sugar specificities. Therefore, we again performed glyco-array 292 analysis using shDC-SIGN dimer as in sSIGNR1. The results clearly showed the recognition of 293 fucose-containing glycans and C. albicans, but not S. cerevisiae, mannan by shDC-SIGN ( Fig.  294 4D), being consistent with our results in lectin ELISA and direct binding to microbes. 295
However, there are some discrepancies in our current observation and previous array 296 results. It has been shown that SIGNR1 can recognize fucose-containing moiety using 297 glyco-array and solid phase competition binding assays (5). One of our previous microarray 298 analyses also demonstrated that hDC-SIGN-Fc fusion was able to bind to glycans from C. 299 albicans and S. cerevisiae (28). In both reports, lectin CRD was fused with the Fc portion of IgG and polymerized with anti-Fc polyclonal Ab, giving rise to a very large and multi-valent 301 complexed probe. In the current glyco-microarray analyses, we utilized dimerized lectin probes, 302 which possibly have lower avidity than those used in previous studies, enabling us to uncover the 303 difference in binding activity of shDC-SIGN to S. cerevisiae and C. albicans glycan. 304 305 Biological significance of the different sugar specificity between SIGNR1 and hDC-SIGN in 306 IL-10 production using RAW264.7 transfectants. To examine the biological significance of 307 distinct saccharide recognition between SIGNR1 and hDC-SIGN, we measured IL-10 production 308 by RAW-SIGNR1 and RAW-hDC-SIGN cells, because hDC-SIGN on DCs is known to induce 309 IL-10 production by recognizing C. albicans (7), and lamina propria DCs expressing SIGNR1 310 are also capable of producing IL-10 (30). After stimulation with C. albicans J-1012 microbe and 311 glycan coated on plastic plate, RAW-hDC-SIGN, but not RAW-SIGNR1, produced IL-10 (data 312 not shown). Therefore, we prepared RAW264.7 cells expressing the chimeric hDC-SIGN 313 molecule (RAW-chimera), of which CRD was replaced with SIGNR1 CRD, to compare glycan 314 recognition specificity in terms of the induction of IL-10 production. The RAW-chimera cells 315 expressed comparable levels of lectin to that of RAW-hDC-SIGN cells (Fig. 5A ). Upon 316 stimulation with S. cerevisiae X2180-1A (WT) glycan, RAW-hDC-SIGN and RAW-chimera 317 cells produced equivalent amounts of IL-10 ( Fig. 5B, upper panel) . RAW-hDC-SIGN produced 318 much less IL-10 in response to S. cerevisiae than C. albicans glycan in comparison with RAW-chimera ( Fig. 5B, lower panel) . Interestingly, in the case of C. albicans J-1012 glycan, 320 RAW-hDC-SIGN produced more IL-10 than RAW-chimera ( Fig. 5B, upper panel) . However, 321
the former significantly reduced IL-10 production after α-mannosidase treatment compared with 322 the latter (Fig. 5C ), being consistent with the results showing that SIGNR1, but not hDC-SING, 323 recognizes β-mannose capped α-mannose side chains in C. albicans glycan. 324
It is feasible that C. albicans induces higher IL-10 production than S. cerevisiae via 325 hDC-SIGN on DCs in humans, leading to the immunosuppressive milieu at the site of infection. 326
This may explain why C. albicans is more virulent than S. cerevisiae. Regarding the sugar 327 specificity of SIGNR1, there were no significant differences in the binding specificity to 328 mannose moieties between C. albicans and S. cerevisiae at the molecular level. However, IL-10 329 production was slightly but significantly higher in response to C. albicans than S. cerevisiae, 330 implying that cellular responses by the recognition through lectin receptors is affected by some 331 other unknown factors. In this study, we used glycans prepared from the blastospore (yeast) form 332 of each yeast strain. However, it should also be kept in mind that the difference in the growth 333 form between C. albicans and S. cerevisiae might modulate cellular activity against microbes in 334 situ. hDC-SIGN in the mouse cells prepared in this study properly transduce signals for IL-10 335 production. Although it is unknown how hDC-SIGN activates the mouse Src family and 336 subsequent Raf-1 kinase in this situation, hDC-SIGN likely has a certain motif that is lacking in 337 SIGNR1, to work in both human and mouse cells for IL-10 production.
Collectively, SIGNR1 and hDC-SIGN bind polysaccharides in surface mannoprotein 340 on live C. albicans. However, SIGNR1 recognizes both α-mannose and β1,2-mannose capped 341 α-mannose side chains composed of more than tri-mannoses, whereas hDC-SIGN recognizes 342 only α-mannose at the non-reductive end of the side chains, but not internal α-mannose capped 343 with β1,2-mannose and short α-mannose chains, of N-glycan side chains in mannoprotein. and S. cerevisiae X2180-1A (WT) glycan in the presence or absence of LPS (100 ng/ml). After 502 24 h, IL-10 in the supernatants was analyzed (upper panel). IL-10 production against S. 503 cerevisiae glycan is shown as a percentage to that against C. albicans glycan (lower panel). (C) 504 IL-10 production after stimulation with native and α-mannosidase-treated C. albicans J-1012 505 glycan was analyzed as in B. IL-10 production against the treated glycan is shown as a 506 percentage to that against the native glycan. **p = 0.0067, ***p = 0.0001 by Student's t-test. 
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